Murphy, N.C. et al. (2008) Expression of LMO4 and outcome in pancreatic ductal adenocarcinoma. British Journal of Cancer, 98(3), pp. 537-541. (doi: 10.1038/sj.bjc.6604177)
|
Text
80796.pdf - Published Version Available under License Creative Commons Attribution Non-commercial Share Alike. 257kB |
Abstract
Identification of a biomarker of prognosis and response to therapy that can be assessed preoperatively would significantly improve overall outcomes for patients with pancreatic cancer. In this study, patients whose tumours exhibited high LMO4 expression had a significant survival advantage following operative resection, whereas the survival of those patients whose tumours had low or no LMO4 expression was not significantly different when resection was compared with operative biopsy alone.
Item Type: | Articles |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Biankin, Professor Andrew |
Authors: | Murphy, N.C., Scarlett, C.J., Kench, J.G., Sum, E.Y.M., Segara, D., Colvin, E.K., Susanto, J., Cosman, P.H., Lee, C.-S., Musgrove, E.A., Sutherland, R.L., Lindeman, G.J., Henshall, S.M., Visvader, J.E., and Biankin, A.V. |
College/School: | College of Medical Veterinary and Life Sciences > School of Cancer Sciences |
Journal Name: | British Journal of Cancer |
Publisher: | Nature Publishing Group |
ISSN: | 0007-0920 |
ISSN (Online): | 1532-1827 |
Copyright Holders: | Copyright © 2008 Cancer Research UK |
First Published: | First published in British Journal of Cancer 98(3):537-541 |
Publisher Policy: | Reproduced under a Creative Commons License |
University Staff: Request a correction | Enlighten Editors: Update this record